UniProt ID | PSIP1_HUMAN | |
---|---|---|
UniProt AC | O75475 | |
Protein Name | PC4 and SFRS1-interacting protein | |
Gene Name | PSIP1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 530 | |
Subcellular Localization | Nucleus . Remains chromatin-associated throughout the cell cycle. | |
Protein Description | Transcriptional coactivator involved in neuroepithelial stem cell differentiation and neurogenesis. Involved in particular in lens epithelial cell gene regulation and stress responses. May play an important role in lens epithelial to fiber cell terminal differentiation. May play a protective role during stress-induced apoptosis. Isoform 2 is a more general and stronger transcriptional coactivator. Isoform 2 may also act as an adapter to coordinate pre-mRNA splicing. Cellular cofactor for lentiviral integration.. | |
Protein Sequence | MTRDFKPGDLIFAKMKGYPHWPARVDEVPDGAVKPPTNKLPIFFFGTHETAFLGPKDIFPYSENKEKYGKPNKRKGFNEGLWEIDNNPKVKFSSQQAATKQSNASSDVEVEEKETSVSKEDTDHEEKASNEDVTKAVDITTPKAARRGRKRKAEKQVETEEAGVVTTATASVNLKVSPKRGRPAATEVKIPKPRGRPKMVKQPCPSESDIITEEDKSKKKGQEEKQPKKQPKKDEEGQKEEDKPRKEPDKKEGKKEVESKRKNLAKTGVTSTSDSEEEGDDQEGEKKRKGGRNFQTAHRRNMLKGQHEKEAADRKRKQEEQMETEQQNKDEGKKPEVKKVEKKRETSMDSRLQRIHAEIKNSLKIDNLDVNRCIEALDELASLQVTMQQAQKHTEMITTLKKIRRFKVSQVIMEKSTMLYNKFKNMFLVGEGDSVITQVLNKSLAEQRQHEEANKTKDQGKKGPNKKLEKEQTGSKTLNGGSDAQDGNQPQHNGESNEDSKDNHEASTKKKPSSEERETEISLKDSTLDN | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
6 | Acetylation | --MTRDFKPGDLIFA --CCCCCCCCCEEEE | 52.99 | 25953088 | |
6 | Ubiquitination | --MTRDFKPGDLIFA --CCCCCCCCCEEEE | 52.99 | 23000965 | |
6 (in isoform 1) | Ubiquitination | - | 52.99 | 21890473 | |
6 (in isoform 2) | Ubiquitination | - | 52.99 | 21890473 | |
14 | Acetylation | PGDLIFAKMKGYPHW CCCEEEEECCCCCCC | 30.32 | 26051181 | |
14 | Ubiquitination | PGDLIFAKMKGYPHW CCCEEEEECCCCCCC | 30.32 | - | |
16 | Malonylation | DLIFAKMKGYPHWPA CEEEEECCCCCCCCC | 55.36 | 26320211 | |
16 | Ubiquitination | DLIFAKMKGYPHWPA CEEEEECCCCCCCCC | 55.36 | 32015554 | |
18 | Phosphorylation | IFAKMKGYPHWPARV EEEECCCCCCCCCCC | 6.09 | 25159151 | |
34 | Acetylation | EVPDGAVKPPTNKLP CCCCCCCCCCCCCCC | 44.75 | 25953088 | |
34 | Ubiquitination | EVPDGAVKPPTNKLP CCCCCCCCCCCCCCC | 44.75 | 27667366 | |
34 (in isoform 1) | Ubiquitination | - | 44.75 | 21890473 | |
34 (in isoform 2) | Ubiquitination | - | 44.75 | 21890473 | |
37 | O-linked_Glycosylation | DGAVKPPTNKLPIFF CCCCCCCCCCCCEEE | 54.21 | 23301498 | |
39 | 2-Hydroxyisobutyrylation | AVKPPTNKLPIFFFG CCCCCCCCCCEEEEE | 59.11 | - | |
39 | Ubiquitination | AVKPPTNKLPIFFFG CCCCCCCCCCEEEEE | 59.11 | 22817900 | |
61 | Phosphorylation | GPKDIFPYSENKEKY CHHHCCCCCCCHHHH | 20.19 | 30576142 | |
62 | Phosphorylation | PKDIFPYSENKEKYG HHHCCCCCCCHHHHC | 34.62 | 25159151 | |
65 | Acetylation | IFPYSENKEKYGKPN CCCCCCCHHHHCCCC | 52.08 | 26051181 | |
65 | Ubiquitination | IFPYSENKEKYGKPN CCCCCCCHHHHCCCC | 52.08 | 32015554 | |
70 | Ubiquitination | ENKEKYGKPNKRKGF CCHHHHCCCCCCCCC | 42.18 | 22817900 | |
73 | Ubiquitination | EKYGKPNKRKGFNEG HHHCCCCCCCCCCCC | 65.10 | 22817900 | |
75 | Sumoylation | YGKPNKRKGFNEGLW HCCCCCCCCCCCCCE | 70.26 | - | |
75 | Sumoylation | YGKPNKRKGFNEGLW HCCCCCCCCCCCCCE | 70.26 | 28112733 | |
75 | Ubiquitination | YGKPNKRKGFNEGLW HCCCCCCCCCCCCCE | 70.26 | 21890473 | |
75 (in isoform 1) | Ubiquitination | - | 70.26 | 21890473 | |
75 (in isoform 2) | Ubiquitination | - | 70.26 | 21890473 | |
89 | Acetylation | WEIDNNPKVKFSSQQ EECCCCCCCCCCCHH | 61.25 | 26051181 | |
89 | Ubiquitination | WEIDNNPKVKFSSQQ EECCCCCCCCCCCHH | 61.25 | 21890473 | |
89 (in isoform 1) | Ubiquitination | - | 61.25 | 21890473 | |
89 (in isoform 2) | Ubiquitination | - | 61.25 | 21890473 | |
91 | Acetylation | IDNNPKVKFSSQQAA CCCCCCCCCCCHHHH | 45.73 | 25953088 | |
91 | Ubiquitination | IDNNPKVKFSSQQAA CCCCCCCCCCCHHHH | 45.73 | - | |
93 | Phosphorylation | NNPKVKFSSQQAATK CCCCCCCCCHHHHHC | 22.86 | 23663014 | |
94 | Phosphorylation | NPKVKFSSQQAATKQ CCCCCCCCHHHHHCC | 29.46 | 28450419 | |
99 | Phosphorylation | FSSQQAATKQSNASS CCCHHHHHCCCCCCC | 32.41 | 23663014 | |
100 | Acetylation | SSQQAATKQSNASSD CCHHHHHCCCCCCCC | 47.18 | 26051181 | |
100 | Ubiquitination | SSQQAATKQSNASSD CCHHHHHCCCCCCCC | 47.18 | 22817900 | |
100 (in isoform 1) | Ubiquitination | - | 47.18 | 21890473 | |
100 (in isoform 2) | Ubiquitination | - | 47.18 | 21890473 | |
102 | Phosphorylation | QQAATKQSNASSDVE HHHHHCCCCCCCCCE | 35.60 | 23927012 | |
105 | Phosphorylation | ATKQSNASSDVEVEE HHCCCCCCCCCEEEE | 31.18 | 29255136 | |
106 | Phosphorylation | TKQSNASSDVEVEEK HCCCCCCCCCEEEEH | 43.17 | 29255136 | |
113 | Ubiquitination | SDVEVEEKETSVSKE CCCEEEEHHCCCCHH | 53.43 | 33845483 | |
115 | Phosphorylation | VEVEEKETSVSKEDT CEEEEHHCCCCHHHC | 45.56 | 23401153 | |
116 | Phosphorylation | EVEEKETSVSKEDTD EEEEHHCCCCHHHCC | 26.03 | 29255136 | |
118 | Phosphorylation | EEKETSVSKEDTDHE EEHHCCCCHHHCCHH | 30.05 | 29255136 | |
119 | Acetylation | EKETSVSKEDTDHEE EHHCCCCHHHCCHHH | 58.41 | 26051181 | |
119 | Ubiquitination | EKETSVSKEDTDHEE EHHCCCCHHHCCHHH | 58.41 | 33845483 | |
122 | Phosphorylation | TSVSKEDTDHEEKAS CCCCHHHCCHHHHHC | 40.11 | 29255136 | |
127 | Ubiquitination | EDTDHEEKASNEDVT HHCCHHHHHCCCCCH | 54.88 | 33845483 | |
129 | Phosphorylation | TDHEEKASNEDVTKA CCHHHHHCCCCCHHH | 52.39 | 29255136 | |
134 | Phosphorylation | KASNEDVTKAVDITT HHCCCCCHHHHHCCC | 26.13 | 22167270 | |
135 | Acetylation | ASNEDVTKAVDITTP HCCCCCHHHHHCCCH | 46.38 | 26051181 | |
135 | Ubiquitination | ASNEDVTKAVDITTP HCCCCCHHHHHCCCH | 46.38 | 22817900 | |
135 (in isoform 1) | Ubiquitination | - | 46.38 | 21890473 | |
135 (in isoform 2) | Ubiquitination | - | 46.38 | 21890473 | |
140 | Phosphorylation | VTKAVDITTPKAARR CHHHHHCCCHHHHHH | 32.36 | 23401153 | |
141 | Phosphorylation | TKAVDITTPKAARRG HHHHHCCCHHHHHHH | 24.11 | 29255136 | |
143 | Ubiquitination | AVDITTPKAARRGRK HHHCCCHHHHHHHCH | 53.22 | 33845483 | |
159 | Phosphorylation | KAEKQVETEEAGVVT HHHHHHCHHCCCEEE | 40.02 | 28176443 | |
166 | Phosphorylation | TEEAGVVTTATASVN HHCCCEEEEEEEEEE | 14.33 | 28176443 | |
167 | Phosphorylation | EEAGVVTTATASVNL HCCCEEEEEEEEEEE | 15.48 | 28176443 | |
169 | Phosphorylation | AGVVTTATASVNLKV CCEEEEEEEEEEEEE | 19.85 | 28176443 | |
171 | Phosphorylation | VVTTATASVNLKVSP EEEEEEEEEEEEECC | 13.74 | 30266825 | |
177 | Phosphorylation | ASVNLKVSPKRGRPA EEEEEEECCCCCCCC | 24.10 | 22167270 | |
180 | Ubiquitination | NLKVSPKRGRPAATE EEEECCCCCCCCCCE | 50.14 | 33845483 | |
186 | Phosphorylation | KRGRPAATEVKIPKP CCCCCCCCEEECCCC | 43.34 | 26074081 | |
189 | Ubiquitination | RPAATEVKIPKPRGR CCCCCEEECCCCCCC | 47.24 | 33845483 | |
192 | Ubiquitination | ATEVKIPKPRGRPKM CCEEECCCCCCCCCC | 51.31 | 33845483 | |
201 | Acetylation | RGRPKMVKQPCPSES CCCCCCCCCCCCCHH | 45.05 | 25953088 | |
201 | Malonylation | RGRPKMVKQPCPSES CCCCCCCCCCCCCHH | 45.05 | 26320211 | |
201 | Methylation | RGRPKMVKQPCPSES CCCCCCCCCCCCCHH | 45.05 | 115972479 | |
201 | Ubiquitination | RGRPKMVKQPCPSES CCCCCCCCCCCCCHH | 45.05 | 33845483 | |
204 | S-palmitoylation | PKMVKQPCPSESDII CCCCCCCCCCHHHCC | 5.54 | 21044946 | |
206 | O-linked_Glycosylation | MVKQPCPSESDIITE CCCCCCCCHHHCCCH | 57.35 | 23301498 | |
206 | Phosphorylation | MVKQPCPSESDIITE CCCCCCCCHHHCCCH | 57.35 | 23401153 | |
207 | Ubiquitination | VKQPCPSESDIITEE CCCCCCCHHHCCCHH | 37.26 | 33845483 | |
208 | Phosphorylation | KQPCPSESDIITEED CCCCCCHHHCCCHHH | 38.15 | 30266825 | |
212 | Phosphorylation | PSESDIITEEDKSKK CCHHHCCCHHHHHHC | 33.39 | 25159151 | |
216 | Acetylation | DIITEEDKSKKKGQE HCCCHHHHHHCCCCH | 68.41 | 23749302 | |
216 | Ubiquitination | DIITEEDKSKKKGQE HCCCHHHHHHCCCCH | 68.41 | 33845483 | |
217 | Phosphorylation | IITEEDKSKKKGQEE CCCHHHHHHCCCCHH | 63.13 | 29083192 | |
220 | Acetylation | EEDKSKKKGQEEKQP HHHHHHCCCCHHCCC | 70.35 | 12435649 | |
225 | Acetylation | KKKGQEEKQPKKQPK HCCCCHHCCCCCCCC | 71.76 | 12435659 | |
228 | Acetylation | GQEEKQPKKQPKKDE CCHHCCCCCCCCCCC | 62.64 | 12435669 | |
229 | Acetylation | QEEKQPKKQPKKDEE CHHCCCCCCCCCCCC | 77.76 | 19810387 | |
232 | Acetylation | KQPKKQPKKDEEGQK CCCCCCCCCCCCCCC | 71.06 | 20167786 | |
242 | Ubiquitination | EEGQKEEDKPRKEPD CCCCCCCCCCCCCCC | 68.31 | 24816145 | |
250 | Sumoylation | KPRKEPDKKEGKKEV CCCCCCCHHHHHHHH | 64.54 | - | |
250 | Sumoylation | KPRKEPDKKEGKKEV CCCCCCCHHHHHHHH | 64.54 | - | |
251 | Sumoylation | PRKEPDKKEGKKEVE CCCCCCHHHHHHHHH | 78.18 | - | |
251 | Ubiquitination | PRKEPDKKEGKKEVE CCCCCCHHHHHHHHH | 78.18 | 24816145 | |
254 | Sumoylation | EPDKKEGKKEVESKR CCCHHHHHHHHHHHH | 47.02 | - | |
254 | Sumoylation | EPDKKEGKKEVESKR CCCHHHHHHHHHHHH | 47.02 | - | |
255 | Sumoylation | PDKKEGKKEVESKRK CCHHHHHHHHHHHHH | 77.25 | - | |
258 | Phosphorylation | KEGKKEVESKRKNLA HHHHHHHHHHHHHHH | 52.19 | 32142685 | |
259 | Phosphorylation | EGKKEVESKRKNLAK HHHHHHHHHHHHHHH | 42.83 | 28258704 | |
263 | Phosphorylation | EVESKRKNLAKTGVT HHHHHHHHHHHHCCC | 49.62 | 32645325 | |
264 | Phosphorylation | VESKRKNLAKTGVTS HHHHHHHHHHHCCCC | 6.08 | 32142685 | |
266 | Phosphorylation | SKRKNLAKTGVTSTS HHHHHHHHHCCCCCC | 49.32 | 32142685 | |
267 | Phosphorylation | KRKNLAKTGVTSTSD HHHHHHHHCCCCCCC | 31.14 | 23927012 | |
270 | Phosphorylation | NLAKTGVTSTSDSEE HHHHHCCCCCCCCCC | 27.86 | 26846344 | |
271 | Phosphorylation | LAKTGVTSTSDSEEE HHHHCCCCCCCCCCC | 24.41 | 26846344 | |
272 | Phosphorylation | AKTGVTSTSDSEEEG HHHCCCCCCCCCCCC | 27.47 | 29255136 | |
273 | Phosphorylation | KTGVTSTSDSEEEGD HHCCCCCCCCCCCCC | 38.62 | 29255136 | |
275 | Phosphorylation | GVTSTSDSEEEGDDQ CCCCCCCCCCCCCCC | 46.83 | 29255136 | |
295 | Ubiquitination | RKGGRNFQTAHRRNM CCCCCCHHHHHHHHH | 41.13 | 24816145 | |
304 | Ubiquitination | AHRRNMLKGQHEKEA HHHHHHHHHHHHHHH | 45.84 | 24816145 | |
324 | Phosphorylation | KQEEQMETEQQNKDE HHHHHHHHHHHHHHC | 33.48 | - | |
333 | Acetylation | QQNKDEGKKPEVKKV HHHHHCCCCHHHHHH | 64.21 | 26051181 | |
346 | Phosphorylation | KVEKKRETSMDSRLQ HHHHHHHHCHHHHHH | 33.13 | 26074081 | |
347 | Phosphorylation | VEKKRETSMDSRLQR HHHHHHHCHHHHHHH | 18.81 | 30576142 | |
350 | Phosphorylation | KRETSMDSRLQRIHA HHHHCHHHHHHHHHH | 26.67 | 26074081 | |
360 | Acetylation | QRIHAEIKNSLKIDN HHHHHHHHHCCCCCC | 31.80 | 26822725 | |
360 | Ubiquitination | QRIHAEIKNSLKIDN HHHHHHHHHCCCCCC | 31.80 | 23000965 | |
364 | Sumoylation | AEIKNSLKIDNLDVN HHHHHCCCCCCCCHH | 48.08 | - | |
364 | Acetylation | AEIKNSLKIDNLDVN HHHHHCCCCCCCCHH | 48.08 | 26051181 | |
364 | Sumoylation | AEIKNSLKIDNLDVN HHHHHCCCCCCCCHH | 48.08 | - | |
364 | Ubiquitination | AEIKNSLKIDNLDVN HHHHHCCCCCCCCHH | 48.08 | 23000965 | |
364 (in isoform 1) | Ubiquitination | - | 48.08 | 21890473 | |
373 | Glutathionylation | DNLDVNRCIEALDEL CCCCHHHHHHHHHHH | 2.51 | 22555962 | |
392 | Acetylation | VTMQQAQKHTEMITT HHHHHHHHHHHHHHH | 56.35 | 21466224 | |
394 | Phosphorylation | MQQAQKHTEMITTLK HHHHHHHHHHHHHHH | 33.99 | 20068231 | |
398 | Phosphorylation | QKHTEMITTLKKIRR HHHHHHHHHHHHHHC | 25.43 | 20068231 | |
399 | Phosphorylation | KHTEMITTLKKIRRF HHHHHHHHHHHHHCC | 26.17 | 20068231 | |
401 | Acetylation | TEMITTLKKIRRFKV HHHHHHHHHHHCCCH | 44.02 | 21466224 | |
401 | Ubiquitination | TEMITTLKKIRRFKV HHHHHHHHHHHCCCH | 44.02 | 32015554 | |
402 | Ubiquitination | EMITTLKKIRRFKVS HHHHHHHHHHCCCHH | 44.55 | 22817900 | |
407 | 2-Hydroxyisobutyrylation | LKKIRRFKVSQVIME HHHHHCCCHHHHHHH | 38.88 | - | |
407 | Malonylation | LKKIRRFKVSQVIME HHHHHCCCHHHHHHH | 38.88 | 26320211 | |
407 | Ubiquitination | LKKIRRFKVSQVIME HHHHHCCCHHHHHHH | 38.88 | 22817900 | |
407 (in isoform 1) | Ubiquitination | - | 38.88 | 21890473 | |
409 | Phosphorylation | KIRRFKVSQVIMEKS HHHCCCHHHHHHHHH | 21.22 | 23401153 | |
415 | Ubiquitination | VSQVIMEKSTMLYNK HHHHHHHHHHHHHHH | 33.57 | 23000965 | |
415 (in isoform 1) | Ubiquitination | - | 33.57 | 21890473 | |
416 | Phosphorylation | SQVIMEKSTMLYNKF HHHHHHHHHHHHHHH | 13.02 | 23401153 | |
417 | Phosphorylation | QVIMEKSTMLYNKFK HHHHHHHHHHHHHHC | 23.43 | 23401153 | |
420 | Phosphorylation | MEKSTMLYNKFKNMF HHHHHHHHHHHCCEE | 12.89 | 23401153 | |
422 | Acetylation | KSTMLYNKFKNMFLV HHHHHHHHHCCEEEE | 44.13 | 25953088 | |
422 | Ubiquitination | KSTMLYNKFKNMFLV HHHHHHHHHCCEEEE | 44.13 | 22817900 | |
422 (in isoform 1) | Ubiquitination | - | 44.13 | 21890473 | |
424 | Ubiquitination | TMLYNKFKNMFLVGE HHHHHHHCCEEEECC | 49.46 | 21890473 | |
424 (in isoform 1) | Ubiquitination | - | 49.46 | 21890473 | |
426 | Sulfoxidation | LYNKFKNMFLVGEGD HHHHHCCEEEECCCC | 2.57 | 28183972 | |
434 | Phosphorylation | FLVGEGDSVITQVLN EEECCCCHHHHHHHC | 26.69 | 26055452 | |
437 | Phosphorylation | GEGDSVITQVLNKSL CCCCHHHHHHHCHHH | 15.52 | 17525332 | |
442 | Neddylation | VITQVLNKSLAEQRQ HHHHHHCHHHHHHHH | 42.56 | 32015554 | |
442 | Ubiquitination | VITQVLNKSLAEQRQ HHHHHHCHHHHHHHH | 42.56 | 23000965 | |
443 | Phosphorylation | ITQVLNKSLAEQRQH HHHHHCHHHHHHHHH | 31.57 | 25159151 | |
461 | Acetylation | NKTKDQGKKGPNKKL HHHHHCCCCCCCCCC | 49.26 | 7663193 | |
462 | Acetylation | KTKDQGKKGPNKKLE HHHHCCCCCCCCCCC | 83.12 | 133527 | |
466 | Acetylation | QGKKGPNKKLEKEQT CCCCCCCCCCCHHHC | 62.97 | 7963435 | |
476 | Acetylation | EKEQTGSKTLNGGSD CHHHCCCCCCCCCCC | 59.38 | 26051181 | |
477 | Phosphorylation | KEQTGSKTLNGGSDA HHHCCCCCCCCCCCC | 27.44 | 25002506 | |
482 | Phosphorylation | SKTLNGGSDAQDGNQ CCCCCCCCCCCCCCC | 31.04 | 28450419 | |
496 | Phosphorylation | QPQHNGESNEDSKDN CCCCCCCCCCCCCCC | 47.09 | 28450419 | |
500 | Phosphorylation | NGESNEDSKDNHEAS CCCCCCCCCCCCHHH | 35.41 | 25159151 | |
507 | Phosphorylation | SKDNHEASTKKKPSS CCCCCHHHCCCCCCH | 37.46 | 23186163 | |
508 | Phosphorylation | KDNHEASTKKKPSSE CCCCHHHCCCCCCHH | 54.66 | 20068231 | |
513 | Phosphorylation | ASTKKKPSSEERETE HHCCCCCCHHHHHHC | 60.30 | 25159151 | |
514 | Phosphorylation | STKKKPSSEERETEI HCCCCCCHHHHHHCE | 52.59 | 23401153 | |
517 | Citrullination | KKPSSEERETEISLK CCCCHHHHHHCEECC | 52.68 | - | |
517 | Citrullination | KKPSSEERETEISLK CCCCHHHHHHCEECC | 52.68 | - | |
519 | Phosphorylation | PSSEERETEISLKDS CCHHHHHHCEECCCC | 44.85 | 30266825 | |
522 | Phosphorylation | EERETEISLKDSTLD HHHHHCEECCCCCCC | 24.12 | 30266825 | |
524 | Acetylation | RETEISLKDSTLDN- HHHCEECCCCCCCC- | 42.73 | 26051181 | |
524 | Ubiquitination | RETEISLKDSTLDN- HHHCEECCCCCCCC- | 42.73 | 22817900 | |
524 (in isoform 1) | Ubiquitination | - | 42.73 | 21890473 | |
526 | Phosphorylation | TEISLKDSTLDN--- HCEECCCCCCCC--- | 29.31 | 25159151 | |
527 | Phosphorylation | EISLKDSTLDN---- CEECCCCCCCC---- | 48.54 | 25159151 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
206 | S | Phosphorylation | Kinase | CDC7 | O00311 | PSP |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of PSIP1_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of PSIP1_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
SRSF1_HUMAN | SRSF1 | physical | 9885563 | |
POL_HV1H2 | gag-pol | physical | 16260736 | |
POL_HV1H2 | gag-pol | physical | 15895093 | |
POL_HV1H2 | gag-pol | physical | 21454548 | |
RS24_HUMAN | RPS24 | physical | 22939629 | |
RL6_HUMAN | RPL6 | physical | 22939629 | |
SON_HUMAN | SON | physical | 22939629 | |
SPB1_HUMAN | FTSJ3 | physical | 22939629 | |
TRA2B_HUMAN | TRA2B | physical | 22939629 | |
SAP18_HUMAN | SAP18 | physical | 22939629 | |
RRS1_HUMAN | RRS1 | physical | 22939629 | |
TPBG_HUMAN | TPBG | physical | 22939629 | |
ZCH18_HUMAN | ZC3H18 | physical | 22939629 | |
RS11_HUMAN | RPS11 | physical | 22939629 | |
TR150_HUMAN | THRAP3 | physical | 22939629 | |
U2AF1_HUMAN | U2AF1 | physical | 22939629 | |
SP16H_HUMAN | SUPT16H | physical | 22939629 | |
HMGA1_HUMAN | HMGA1 | physical | 18850631 | |
HMGA2_HUMAN | HMGA2 | physical | 18850631 | |
SUMO1_HUMAN | SUMO1 | physical | 22748127 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-106; THR-141; THR-167;SER-177; SER-273; SER-275 AND SER-522, AND MASS SPECTROMETRY. | |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-105; SER-106; THR-141;THR-270; THR-272; SER-273 AND SER-275, AND MASS SPECTROMETRY. | |
"Large-scale phosphoproteome analysis of human liver tissue byenrichment and fractionation of phosphopeptides with strong anionexchange chromatography."; Han G., Ye M., Zhou H., Jiang X., Feng S., Jiang X., Tian R., Wan D.,Zou H., Gu J.; Proteomics 8:1346-1361(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-273 AND SER-275, ANDMASS SPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-106; THR-141; SER-271;THR-272; SER-273; SER-275; SER-434; SER-443; SER-522 AND THR-527, ANDMASS SPECTROMETRY. | |
"Global proteomic profiling of phosphopeptides using electron transferdissociation tandem mass spectrometry."; Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A.; Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-106; THR-122; SER-129;SER-273 AND SER-275, AND MASS SPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-122; SER-273 ANDSER-275, AND MASS SPECTROMETRY. | |
"Global phosphoproteome of HT-29 human colon adenocarcinoma cells."; Kim J.-E., Tannenbaum S.R., White F.M.; J. Proteome Res. 4:1339-1346(2005). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-275, AND MASSSPECTROMETRY. | |
"Large-scale characterization of HeLa cell nuclear phosphoproteins."; Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,Li J., Cohn M.A., Cantley L.C., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-106, AND MASSSPECTROMETRY. | |
"ATM and ATR substrate analysis reveals extensive protein networksresponsive to DNA damage."; Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.; Science 316:1160-1166(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-437, AND MASSSPECTROMETRY. | |
"A probability-based approach for high-throughput proteinphosphorylation analysis and site localization."; Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.; Nat. Biotechnol. 24:1285-1292(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-141, AND MASSSPECTROMETRY. |